🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Qlaris Phase 2 clinical study investigating the safety, tolerability, and o...
Status
Completed
Location
Berkeley Eye Center
Start Date
2024-04-21
Trial ID
NCT06249152
Treatments Being Tested
The purpose of this study is to explore the efficacy and safety of CsA opht...
Status
Completed
Location
Ophthalmological Center of Zhongshan University
Start Date
2020-11-05
Trial ID
NCT04541888
Treatments Being Tested
The purpose of the study is to evaluate the safety and effectiveness of an ...
Status
Completed
Location
Multiple Locations
Start Date
2004-07
Trial ID
NCT00293800
To evaluate the efficacy of Combo compared to its individual components and...
Status
Completed
Location
104 Butchertown Clinical Trials
Start Date
2022-11-18
Trial ID
NCT05591755
The purpose of this study is to determine the safety and IOP-lowering abili...
Status
Completed
Location
Multiple Locations
Start Date
2003-07
Trial ID
NCT00069706
This is a Phase 2 clinical study designed to evaluate the safety and effica...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2027-09-01
Trial ID
NCT07625124
Treatments Being Tested
The purpose of this study was to evaluate the ocular safety of an investiga...
Status
Completed
Location
Multiple Locations
Start Date
2012-10
Trial ID
NCT01698814
Treatments Being Tested
Qlaris' Phase 2 clinical trial investigating the safety, tolerability, and ...
Status
Completed
Location
Coastal Research Associates, LLC
Start Date
2024-03-05
Trial ID
NCT06016972
This is a phase III double-masked, randomized, controlled study evaluating ...
Status
Completed
Location
Investigational Site
Start Date
2014-01
Trial ID
NCT01998802
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of an inve...
Status
Not Yet Recruiting
Location
Contact Alcon Call Center for Trial Locations
Start Date
2026-09
Trial ID
NCT07578363
Treatments Being Tested